drugset / Trial / NCT03550183
Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Parkinson's Disease
NaSingle-groupOpen-labelTreatment
Summary
This study is to evaluate the safety and efficacy of Umbilical Cord Derived Mesenchymal Stem Cells transplantation in Parkinson's disease.
Timeline
- Start
- 2018-01-10
- Primary completion
- 2022-10-10
- Completion
- 2022-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | mesenchymal stem cells | Cell therapy | 1e+07 cells | Intravenous |
| Subject | mesenchymal stem cells | Cell therapy | 2e+07 cells | Intravenous |